alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 73 FR 62506-07, dated October 21, 2008) is amended to reflect the reorganization of the Division of Healthcare Quality Promotion within the National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention.

Section C-B, Organization and Functions, is hereby amended as follows: After item (5) of the functional statement for the Division of Healthcare Quality Promotion (CVKD), insert the following and renumber the remaining items accordingly: (6) monitors vaccine safety and conducts scientific research to evaluate the safety of all currently available and new vaccines;

After item (13) of the functional statement for the Office of the Director (CVKD1), insert the following and renumber the remaining items accordingly: (14) coordinates vaccine safety activities at CDC; (15) leads CDC activities to monitor vaccine safety; (16) leads CDC's scientific research to evaluate the safety of all currently available and new vaccines.

Dated: October 5, 2009.

William P. Nichols,

Acting Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. E9-24672 Filed 10-13-09; 8:45 am]

BILLING CODE 4160-18-M
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<CURRENCY>  0

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-1998
<PERIOD-START>                             JAN-01-1999             JAN-01-1998
<PERIOD-END>                               JUN-30-1999             JUN-30-1998
<EXCHANGE-RATE>                                   1.00                    1.00
<CASH>                                          28,278                  66,185
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    1,222                   1,222
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                       0
<PP&E>                                         311,105                 596,517
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                               1,882,530               2,214,565
<CURRENT-LIABILITIES>                                0                   1,632
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             0                       0
<OTHER-SE>                                   1,882,530               2,212,933
<TOTAL-LIABILITY-AND-EQUITY>                 1,882,530               2,214,565
<SALES>                                              0                       0
<TOTAL-REVENUES>                                   599                 317,854
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                                19,484                  24,105
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                                (18,885)                293,749
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                            (18,885)                293,749
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (18,885)                293,749
<EPS-BASIC>                                        0                       0
<EPS-DILUTED>                                        0                       0


</TABLE>
Exhibit 10.2

                                    NORTHLAND
                                 CRANBERRIES, INC.          JOHN SWENDROWSKI
                                                             CHAIRMAN & CEO


                                 April 21, 2000


Mr. Scott R. Corriveau
5810 High Point Court
Wisconsin Rapids, WI  54494

Dear Scott:

     This letter will  confirm the mutual  agreement  between you and  Northland
Cranberries,  Inc. (the "Company") to terminate the Key Executive Employment and
Severance  Agreement,  dated as of December 7, 1998,  by and between you and the
Company (the  "Agreement"),  on the terms and conditions  set forth herein.  The
Company and you hereby  agree that the  Agreement  will be  terminated  and that
neither  you nor the  Company  will  have  any  further  rights  or  obligations
thereunder  effective  as of the day  prior to the  consummation  of a Change in
Control of the Company (as defined in the Northland Cranberries,  Inc. Severance
and Stay Bonus Plan (the  "Plan")) in exchange for the benefits  provided to you
under the Plan as adopted by the Board of  Directors  of the  Company  effective
April 14, 2000.  If the Plan is amended in any way adverse to your  interests or
is  terminated  prior to a Change in Control of the  Company,  then this  letter
agreement shall be null and void.

                                       Very truly yours,

                                       /s/ John Swendrowski

                                       John Swendrowski
                                       Chairman and CEO


Agreed to and Accepted this 21st day of April, 2000


/s/ Scott R. Corriveau
----------------------------
Scott R. Corrieveau


800 First  Avenue  South * P.O.  Box 8020 * Wisconsin  Rapids,  WI  54495-8020 *
715-424-4444 * Fax 715-422-6800
(1)
    
    Registration Statement (Form S-3 No. 333-121724) of Human Genome Sciences, Inc.,(2)
    
    Registration Statement (Form S-3 No. 333-128874) of Human Genome Sciences, Inc.,(3)
    
    Registration Statement (Form S-3 No. 333-162731) of Human Genome Sciences, Inc.,(4)
    
    Registration Statement (Form S-8 No. 333-44798) of Human Genome Sciences, Inc. 2000
Stock Incentive Plan and Human Genome Sciences, Inc. Employee Stock Purchase Plan,(5)
    
    Registration Statement (Form S-8 No. 333-66670) of Human Genome Sciences, Inc. Amended
and Restated 2000 Stock Incentive Plan,(6)
    
    Registration Statement (Form S-8 No. 333-89392) of Human Genome Sciences, Inc. Amended
and Restated 2000 Stock Incentive Plan,(7)
    
    Registration Statement (Form S-8 No. 333-104219) of Human Genome Sciences, Inc. Amended
and Restated 2000 Stock Incentive Plan,(8)
    
    Registration Statement (Form S-8 No. 333-142713) of Human Genome Sciences, Inc.
Employee Stock Purchase Plan and Non-Employee Director Equity Compensation Plan,(9)
    
    Registration Statement (Form S-8 No. 333-156334) of Human Genome Sciences, Inc.
Employee Stock Purchase Plan,(10)
    
    Registration Statement (Form S-8 No. 333-159003) of Human Genome Sciences, Inc. Amended
and Restated Stock Incentive Plan
Order issued January [ -’[ ,2013

In The

No. 05-12-01681-CV

WALTER MITCHELL, Appellant

VO

TONYA CHANDLER; FRANK FORSHEE, PATRICK PARKER, AND

.. --_ LETRICIA TARRANT, Appellees

ORDER

The Court GRANTS appellant’s January 14, 2013 motion for extension of time to file his

jurisdictional letter brief. Appellant shall file his letter brief no later than February 1, 2013.

Appellees shall file any response no later than February 11, 2013.
I

Clerk, Sth District MA TZ
§ 1291.22 Funding rounds; application process. ( a ) *Funding rounds.* A Bank may accept applications from proposed projects for AHP subsidy under its General Fund and any Targeted Funds during a specified number of funding rounds each year, as determined by the Bank.
( b ) *Submission of applications.* Except as provided in § 1291.29(a), a Bank shall require applications for AHP subsidy to contain information sufficient for the Bank to: ( 1 ) Determine that the proposed AHP project meets the eligibility requirements of this part; and
( 2 ) Evaluate the application pursuant to the scoring methodology adopted by the Bank pursuant to §§ 1291.25, 1291.26, and 1291.27, as applicable.
( c ) *Review of applications submitted.* Except as provided in § 1291.29(b), a Bank shall review the applications for AHP subsidy to determine that the proposed AHP project meets the eligibility requirements of this part, and shall evaluate the applications pursuant to the Bank's scoring methodology adopted pursuant to §§ 1291.25, 1291.26, and 1291.27, as applicable.
[Federal Register Volume 74, Number 196 (Tuesday, October 13, 2009)]
[Notices]
[Page 52488]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24553]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-8967-8]


2009 Fall Meeting of the Ozone Transport Commission

AGENCY: Environmental Protection Agency.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The United States Environmental Protection Agency is 
announcing the 2009 Fall Meeting of the Ozone Transport Commission 
(OTC). This OTC meeting will explore options available for reducing 
ground-level ozone precursors in a multi-pollutant context.

DATES: The meeting will be held on November 5, 2009 starting at 9 a.m. 
(EST) and ending at 5 p.m.

ADDRESSES: Hotel Monaco Baltimore, 2 North Charles Street, Baltimore, 
MD 21201; (443) 692-6170.

FOR FURTHER INFORMATION CONTACT: For documents and press inquiries 
contact: Ozone Transport Commission, 444 North Capitol Street, NW., 
Suite 638, Washington, DC 20001; (202) 508-3840; e-mail: 
<a href="/cdn-cgi/l/email-protection#47283d28292207283324262e3569283520"><span class="__cf_email__" data-cfemail="9bf4e1f4f5fedbf4eff8faf2e9b5f4e9fc">[email protected]</span></a>; Web site: www.otcair.org.

SUPPLEMENTARY INFORMATION: The Clean Air Act Amendments of 1990 contain 
at Section 184 provisions for the ``Control of Interstate Ozone Air 
Pollution.'' Section 184(a) establishes an ``Ozone Transport Region'' 
(OTR) comprised of the States of Connecticut, Delaware, Maine, 
Maryland, Massachusetts, New Hampshire, New Jersey, New York, 
Pennsylvania, Rhode Island, Vermont, parts of Virginia and the District 
of Columbia. The purpose of the Ozone Transport commission is to deal 
with ground-level ozone formation, transport, and control within the 
OTR.
    Type of Meeting: Open.
    Agenda: Copies of the final agenda will be available from the OTC 
office (202) 508-3840; by e-mail: <a href="/cdn-cgi/l/email-protection#701f0a1f1e15301f04131119025e1f0217"><span class="__cf_email__" data-cfemail="a8c7d2c7c6cde8c7dccbc9c1da86c7dacf">[email protected]</span></a>; or via the OTC Web 
site at http://www.otcair.org.

    Dated: September 30, 2009.
 James W. Newsom,
Acting Regional Administrator, Region III.
[FR Doc. E9-24553 Filed 10-9-09; 8:45 am]
BILLING CODE 6560-50-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2020090EN.01000201.xml

| 19.3.2020 | EN | Official Journal of the European Union | C 90/2 |
| --- | --- | --- | --- |

19.3.2020

EN

Official Journal of the European Union

C 90/2

---

JUDGMENT OF THE COURT

of 14 December 2019

in Case E-1/19

Andreas Gyrre

v

The Norwegian Government, represented by the Ministry of Children and Equality

(Directive 2005/29/EC – Unfair business-to-consumer commercial practices – Annex I – Point 9 – Stating or otherwise creating the impression that a product can legally be sold when it cannot)

(2020/C 90/02)

In Case E-1/19, Andreas Gyrre v The Norwegian Government, represented by the Ministry of Children and Equality – REQUEST to the Court under Article 34 of the Agreement between the EFTA States on the Establishment of a Surveillance Authority and a Court of Justice by Borgarting Court of Appeal (Borgarting lagmannsrett) concerning the interpretation of Directive 2005/29/EC of the European Parliament and of the Council of 11 May 2005 concerning unfair business-to-consumer commercial practices in the internal market and amending Council Directive 84/450/EEC, Directives 97/7/EC, 98/27/EC and 2002/65/EC of the European Parliament and of the Council and Regulation (EC) No 2006/2004 of the European Parliament and of the Council, and in particular point 9 of Annex I thereto, the Court, composed of Páll Hreinsson, President, Bernd Hammermann (Judge-Rapporteur), and Siri Teigum (ad hoc Judge), gave judgment on 14 December 2019, the operative part of which is as follows:

Point 9 of Annex I to Directive 2005/29/EC of the European Parliament and of the Council of 11 May 2005 concerning unfair business-to-consumer commercial practices in the internal market and amending Council Directive 84/450/EEC, Directives 97/7/EC, 98/27/EC and 2002/65/EC of the European Parliament and of the Council and Regulation (EC) No 2006/2004 of the European Parliament and of the Council must be interpreted as encompassing situations in which a trader states or otherwise creates the impression, based on the overall impression conveyed to the average consumer at the time of the transactional decision, that a product can legally be sold when it cannot. It does not have a bearing on that assessment whether such a national legislative prohibition, as in the present case, applies in either the EEA State of sale or the EEA State of performance or in both. Nor is that assessment affected by the national legislative prohibition in question being subsequently found to be contrary to EEA law.

---
§ 332.1 Purpose and scope. ( a ) *Purpose.* This part governs the treatment of nonpublic personal information about consumers by the financial institutions listed in paragraph (b) of this section. This part: ( 1 ) Requires a financial institution to provide notice to customers about its privacy policies and practices;
( 2 ) Describes the conditions under which a financial institution may disclose nonpublic personal information about consumers to nonaffiliated third parties; and
( 3 ) Provides a method for consumers to prevent a financial institution from disclosing that information to most nonaffiliated third parties by “opting out” of that disclosure, subject to the exceptions in §§ 332.13, 332.14, and 332.15.
( b ) *Scope.* ( 1 ) This part applies only to nonpublic personal information about individuals who obtain financial products or services primarily for personal, family, or household purposes from the institutions listed below. This part does not apply to information about companies or about individuals who obtain financial products or services for business, commercial, or agricultural purposes. This part applies to the United States offices of entities for which the Federal Deposit Insurance Corporation (FDIC) has primary federal supervisory authority. They are referred to in this part as “you.” These are: banks insured by the FDIC (other than members of the Federal Reserve System), insured state branches of foreign banks, and certain subsidiaries of such entities.
( 2 ) Nothing in this part modifies, limits, or supersedes the standards governing individually identifiable health information promulgated by the Secretary of Health and Human Services under the authority of sections 262 and 264 of the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. 1320d-1320d-8).
<PAGE>   1




                                                                      EXHIBIT 21
                                                                     PAGE 1 OF 1

                               THOMAS GROUP, INC.
                           SUBSIDIARIES OF THE COMPANY


<TABLE>
<CAPTION>

               SUBSIDIARY                                                               JURISDICTION OF INCORPORATION
------------------------------------------                                         ----------------------------------------
<S>                                                                                 <C>
            Thomas Group GmbH                                                                      Germany
     Thomas Group (Switzerland) GmbH                                                             Switzerland
     Thomas Group of Louisiana, Inc.                                                              Delaware
       Thomas Group Asia Pte. Ltd.                                                                Singapore
         Thomas Group of Sweden                                                                    Sweden
         Thomas Group Hong Kong                                                                   Hong Kong
         Thomas Group Information
           Technologies, Inc.                                                                      Delaware
</TABLE>
# C_2014020EN.01000701.xml

| 23.1.2014 | EN | Official Journal of the European Union | C 20/7 |
| --- | --- | --- | --- |

23.1.2014

EN

Official Journal of the European Union

C 20/7

---

Announcement

Publication of Oppland County’s intention to enter into three contracts concerning local public transport by bus, pursuant to Article 7(2) of Regulation (EC) No 1370/2007 of the European Parliament and of the Council on public passenger transport services by rail and by road and repealing Council Regulations (EEC) Nos 1191/69 and 1107/70

(2014/C 20/07)

1.   Name and address of the competent authority

Name and address of the competent authority

| Oppland fylkeskommune |
| --- |
| Opplandstrafikk |
| Kirkegata 76 |
| Postboks 988 |
| 2626 Lillehammer |
| NORWAY |

Oppland fylkeskommune

Opplandstrafikk

Kirkegata 76

Postboks 988

2626 Lillehammer

NORWAY

2.   Type of award envisaged

Type of award envisaged

Directly awarded contract pursuant to the exceptions in Article 5(4) of Regulation (EC) No 1370/2007 of the European Parliament and of the Council.

3.   Services and areas potentially covered by the award

Services and areas potentially covered by the award

Passenger transport by bus in Torpa and surroundings (mainly in the municipality of Nordre Land). The transport amounts to about 300 000 km yearly.

1.   Name and address of the competent authority

Name and address of the competent authority

| Oppland fylkeskommune |
| --- |
| Opplandstrafikk |
| Kirkegata 76 |
| Postboks 988 |
| 2626 Lillehammer |
| NORWAY |

Oppland fylkeskommune

Opplandstrafikk

Kirkegata 76

Postboks 988

2626 Lillehammer

NORWAY

2.   Type of award envisaged

Type of award envisaged

Directly awarded contract pursuant to the exceptions in Article 5(4) of Regulation (EC) No 1370/2007 of the European Parliament and of the Council.

3.   Services and areas potentially covered by the award

Services and areas potentially covered by the award

Passenger transport by bus in Snertingdal and Biri in the municipality of Gjøvik. The transport amounts to about 470 000 km yearly.

1.   Name and address of the competent authority

Name and address of the competent authority

| Oppland fylkeskommune |
| --- |
| Opplandstrafikk |
| Kirkegata 76 |
| Postboks 988 |
| 2626 Lillehammer |
| NORWAY |

Oppland fylkeskommune

Opplandstrafikk

Kirkegata 76

Postboks 988

2626 Lillehammer

NORWAY

2.   Type of award envisaged

Type of award envisaged

Directly awarded contract pursuant to the exceptions in Article 5(4) of Regulation (EC) No 1370/2007 of the European Parliament and of the Council.

3.   Services and areas potentially covered by the award

Services and areas potentially covered by the award

Passenger transport by bus in Etnedal and Begnadalen, mainly in the municipalities of Etnedal and Bagn. The transport amounts to about 417 000 km yearly.

---
#### § 366.9 What other requirements could prevent me from performing contractual services for the FDIC?

You must avoid a conflict of interest, be ethically responsible, and maintain confidential information as described in §§ 366.10 through 366.13. You must also provide us with the information we require in § 366.14. Failure to meet these requirements may prevent you from contracting with us.
HomeOffice of the SpokespersonPress Releases...Sanctioning Cuban Officials in Response to Violence against Peaceful Protestors

# 									Sanctioning Cuban Officials in Response to Violence against Peaceful Protestors							

Press Statement

Antony J. Blinken, Secretary of State

August 19, 2021

The United States has imposed additional sanctions on Cuban military and security leaders in response to the Cuban regime’s continued violent suppression of freedoms of expression and peaceful assembly in the days and weeks following the protests on and after July 11.

The United States designated Andres Laureano Gonzalez Brito, Chief of the Central Army under the Ministry of the Revolutionary Armed Forces (MINFAR); Roberto Legra Sotolongo, Deputy Chief of the General Staff and Chief of the Directorate of Operations under MINFAR; and Abelardo Jimenez Gonzalez, Chief of the Directorate of Penitentiary Establishments of the Cuban Ministry of the Interior (MININT).  We are taking this action pursuant to Executive Order 13818, which builds upon and implements the Global Magnitsky Human Rights Accountability Act.

Gonzalez Brito and Legra Sotolongo are senior officials under MINFAR, which has engaged in brutal actions to repress peaceful protestors.  Under Jimenez Gonzalez, the MININT Directorate of Prisons has held protestors without due process and in a number of cases has not disclosed prisoners’ whereabouts to family members.  There are credible reports of abuse of prisoners while in detention.

We stand in solidarity with every brave Cuban in their call for human rights and fundamental freedoms.  Through the Global Magnitsky sanctions program, the United States seeks to impose tangible and significant consequences for the Cuban regime’s ongoing repression of its people, including the unjust detentions of hundreds of protesters, journalists, and activists.  We will continue to provide support to Cubans as they seek to exercise human rights and fundamental freedoms, to which all individuals are entitled, and will take action to promote accountability for the Cuban government’s human rights abuses.

Tags

Bureau of Western Hemisphere AffairsCubaOffice of the SpokespersonThe Secretary of State

Back to Top